696-00-4

Upstream product

• 140-89-6 potassium ethyl xanthogenate 
• 6096-20-4 3-chloro-4-hydroxyphenyl thiocyanate 

Downstream Products

• 103861-38-7 2-chloro-4-pentylsulfanyl-phenol 
• 107624-64-6 4-benzylsulfanyl-2-chloro-phenol 
• 17733-32-3 2-chloro-4-(methylthio)phenol 
• 1159113-28-6 4-{[(3-chloro-4-hydroxyphenyl)thio]methyl}benzaldehyde 
• 109866-38-8 1-benzoyloxy-2-chloro-4-phenylmethanesulfonyl-benzene 
• 109866-37-7 1-benzoyloxy-4-benzylsulfanyl-2-chloro-benzene 
• 107624-69-1 2-chloro-4-phenylmethanesulfonyl-phenol 
• 103861-42-3 2-chloro-4-(pentane-1-sulfonyl)-phenol 

Relevant academic research and scientific papers

NOVEL GLUCOCORTICOID RECEPTOR AGONISTS

This invention relates to novel glucocorticoid receptor agonists of formula (I) and to processes and intermediates for their preparation. The present invention also relates to pharmaceutical compositions containing these compounds, to their combination with one or more other therapeutic agents, as well as to their use for the treatment of a number of inflammatory and allergic diseases, disorders and conditions.

NOVEL GLUCOCORTICOID RECEPTOR AGONISTS

This invention relates to novel glucocorticoid receptor agonists of formula (I) and to processes and intermediates for their preparation. The present invention also relates to pharmaceutical compositions containing these compounds, to their combination with one or more other therapeutic agents, as well as to their use for the treatment of a number of inflammatory and allergic diseases, disorders and conditions.

CHROMONE DERIVATIVE, AND ALDOSE REDUCTASE INHIBITOR COMPRISING SAID COMPOUND AS ACTIVE COMPONENT

The present invention relates to a chromone derivative and an aldose reductase inhibitor comprising said compound as efective component, which is represented by the following formula:wherein R1 and R2 each represent a lower alkyl group, etc., R3 represent